Forlenza, Gregory P.

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

Brown, S. A., Kovatchev, B. P., Raghinaru, D., Lum, J. W., Buckingham, B. A., Kudva, Y. C., Laffel, L. M., Levy, C. J., Pinsker, J. E., Wadwa, R. P., et al. (2019) · New England Journal of Medicine

Diabetes Management and ResearchDiabetes Management and Education

Cited by 1,030

A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes

Breton, M. D., Kanapka, L. G., Beck, R. W., Ekhlaspour, L., Forlenza, G. P., Cengiz, E., Schoelwer, M., Ruedy, K. J., Jost, E., Carria, L., et al. (2020) · New England Journal of Medicine

Diabetes Management and ResearchDiabetes Management and Education

Cited by 455

Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice

Phillip, M., Nimri, R., Bergenstal, R. M., Barnard-Kelly, K., Danne, T., Hovorka, R., Kovatchev, B. P., Messer, L. H., Parkin, C. G., Ambler-Osborn, L., et al. (2023) · Endocrine Reviews

Diabetes Management and ResearchDiabetes Management and Education

Cited by 443

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

Klonoff, D. C., Wang, J., Rodbard, D., Kohn, M. A., Li, C., Liepmann, D., Kerr, D., Ahn, D., Peters, A. L., Umpierrez, G. E., et al. (2023) · Journal of Diabetes Science and Technology

Diabetes Management and ResearchDiabetes Management and Education

Cited by 295

Predictive low-glucose suspend reduces hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: results of the PROLOG trial

Forlenza, G. P., Li, Z., Buckingham, B. A., Pinsker, J. E., Cengiz, E., Wadwa, R. P., Ekhlaspour, L., Church, M. M., Weinzimer, S. A., Jost, E., et al. (2018) · Diabetes Care

Diabetes Management and ResearchDiabetes Management and Education

Cited by 246

Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes

Nimri, R., Battelino, T., Laffel, L. M., Slover, R. H., Schatz, D., Weinzimer, S. A., Dovc, K., Danne, T., Phillip, M., NextDREAM Consortium, et al. (2020) · Nature Medicine

Diabetes Management and ResearchDiabetes Management and Education

Cited by 242

ISPAD Clinical Practice Consensus Guidelines 2018: diabetes technologies

Sherr, J. L., Tauschmann, M., Battelino, T., de Bock, M., Forlenza, G., Roman, R., Hood, K. K., & Maahs, D. M. (2018) · Pediatric Diabetes

Diabetes Management and ResearchDiabetes Management and Education

Cited by 197

Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes

Wadwa, R. P., Reed, Z. W., Buckingham, B. A., DeBoer, M. D., Ekhlaspour, L., Forlenza, G. P., Schoelwer, M., Lum, J., Kollman, C., Beck, R. W., et al. (2023) · New England Journal of Medicine

Diabetes Management and ResearchDiabetes Management and Education

Cited by 191

Closed-Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study

Breton, M. D., Cherñavvsky, D. R., Forlenza, G. P., DeBoer, M. D., Robic, J., Wadwa, R. P., Messer, L. H., Kovatchev, B. P., & Maahs, D. M. (2017) · Diabetes Care

Diabetes Management and ResearchDiabetes Management and Education

Cited by 179

Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes

Alva, S., Bailey, T., Brazg, R., Budiman, E. S., Castorino, K., Christiansen, M. P., Forlenza, G., Kipnes, M., Liljenquist, D. R., & Liu, H. (2022) · Journal of Diabetes Science and Technology

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 164

A clinical guide to advanced diabetes devices and closed-loop systems using the CARES paradigm

Messer, L. H., Berget, C., & Forlenza, G. P. (2019) · Diabetes Technology & Therapeutics

Diabetes Management and ResearchDiabetes Management and Education

Cited by 100

Real-World Evidence of Omnipod ® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes

Forlenza, G. P., DeSalvo, D. J., Aleppo, G., Wilmot, E. G., Berget, C., Huyett, L. M., Hadjiyianni, I., Méndez, J. J., Conroy, L. R., Ly, T. T., et al. (2024) · Diabetes Technology & Therapeutics

Diabetes Management and ResearchDiabetes Management and Education

Cited by 99

Safety and performance of the Omnipod hybrid closed-loop system in adults, adolescents, and children with type 1 diabetes over 5 days under free-living conditions

Sherr, J. L., Buckingham, B. A., Forlenza, G. P., Galderisi, A., Ekhlaspour, L., Wadwa, R. P., Carria, L., Hsu, L., Berget, C., Peyser, T. A., et al. (2020) · Diabetes Technology & Therapeutics

Diabetes Management and ResearchDiabetes and associated disorders

Cited by 92

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes

Laffel, L. M., Aleppo, G., Buckingham, B. A., Forlenza, G. P., Rasbach, L. E., Tsalikian, E., Weinzimer, S. A., & Harris, D. R. (2017) · Journal of the Endocrine Society

Diabetes Management and ResearchDiabetes Management and Education

Cited by 79

Real-world evidence supporting Tandem Control-IQ hybrid closed-loop success in the Medicare and Medicaid type 1 and type 2 diabetes populations

Forlenza, G. P., Carlson, A. L., Galindo, R. J., Kruger, D. F., Levy, C. J., McGill, J. B., Umpierrez, G., & Aleppo, G. (2022) · Diabetes Technology & Therapeutics

Diabetes Management and ResearchDiabetes Management and Education

Cited by 70

Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control

Huyett, L. M., Ly, T. T., Forlenza, G. P., Reuschel-DiVirgilio, S., Messer, L. H., Wadwa, R. P., Gondhalekar, R., Doyle, F. J., Pinsker, J. E., Maahs, D. M., et al. (2017) · Diabetes Technology & Therapeutics

Diabetes Management and ResearchDiabetes Management and Education

Cited by 64

Coverage for Continuous Glucose Monitoring for Individuals with Type 2 Diabetes Treated with Nonintensive Therapies: An Evidence-Based Approach to Policymaking

Aleppo, G., Hirsch, I. B., Parkin, C. G., McGill, J., Galindo, R., Kruger, D. F., Levy, C. J., Forlenza, G. P., Umpierrez, G. E., Grunberger, G., et al. (2023) · Diabetes Technology & Therapeutics

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 34

Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes

Karlin, A. W., Ly, T. T., Pyle, L., Forlenza, G. P., Messer, L., Wadwa, R. P., DeSalvo, D. J., Payne, S. L., Hanes, S., Clinton, P., et al. (2016) · Diabetes Technology & Therapeutics

Diabetes Management and ResearchIntravenous Infusion Technology and Safety

Cited by 32

Real-Time Detection of Infusion Site Failures in a Closed-Loop Artificial Pancreas

Howsmon, D. P., Baysal, N., Buckingham, B. A., Forlenza, G. P., Ly, T. T., Maahs, D. M., Marcal, T., Towers, L., Mauritzen, E., Deshpande, S., et al. (2018) · Journal of Diabetes Science and Technology

Diabetes Management and ResearchIntravenous Infusion Technology and Safety

Cited by 32

Continuous Glucose Monitoring Enables the Detection of Losses in Infusion Set Actuation (LISAs)

Howsmon, D., Cameron, F., Baysal, N., Ly, T., Forlenza, G., Maahs, D., Buckingham, B., Hahn, J., & Bequette, B. (2017) · Sensors

Diabetes Management and ResearchFault Detection and Control Systems

Cited by 27